TBIO (OTC)
TELESIS BIO INC
$0.051000
+0.000000 (+0.00%)
Prev close: $0.051000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ronald C. Renaud, Jr., MBA
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $2,823.92M
- Employees
- —
- P/E (TTM)
- 74.36
- P/B (TTM)
- 6.82
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2024 (Q3)
|
$-3.83 | $-6.71 | +2.8816 | +42.93% |
|
Jun 2024 (Q2)
|
$-7.62 | $-4.11 | -3.5094 | -85.37% |
|
Mar 2024 (Q1)
|
$-5.52 | $-4.22 | -1.2972 | -30.72% |
|
Dec 2023 (Q4)
|
$-4.14 | $-4.04 | -0.1008 | -2.50% |
Financial Statements
| Revenues | $225.09M |
| Benefits Costs and Expenses | $64.31M |
| Costs And Expenses | $186.04M |
| Operating Expenses | $186.35M |
| Research and Development | $140.81M |
| Operating Income/Loss | $38.74M |
| Income/Loss From Continuing Operations After Tax | $40.45M |
| Income/Loss From Continuing Operations Before Tax | $111.68M |
| Net Income/Loss | $40.45M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $40.45M |
| Net Income/Loss Available To Common Stockholders, Basic | $40.45M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.60 |
| Diluted Earnings Per Share | $0.56 |
| Assets | $904.87M |
| Current Assets | $717.01M |
| Noncurrent Assets | $187.86M |
| Fixed Assets | $18.25M |
| Intangible Assets | $74.51M |
| Other Non-current Assets | $95.10M |
| Liabilities | $492.23M |
| Current Liabilities | $81.51M |
| Accounts Payable | $13.74M |
| Wages | $5.33M |
| Other Current Liabilities | $62.45M |
| Noncurrent Liabilities | $410.72M |
| Equity | $412.64M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $412.64M |
| Liabilities And Equity | $904.87M |
| Net Cash Flow From Operating Activities | $301.50M |
| Net Cash Flow From Operating Activities, Continuing | $301.50M |
| Net Cash Flow From Investing Activities | -$403.65M |
| Net Cash Flow From Investing Activities, Continuing | -$403.65M |
| Net Cash Flow From Financing Activities | $83.31M |
| Net Cash Flow From Financing Activities, Continuing | $83.31M |
| Net Cash Flow | -$18.85M |
| Net Cash Flow, Continuing | -$18.85M |
| Comprehensive Income/Loss | $40.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $39.94M |
| Other Comprehensive Income/Loss | $43.70M |